Immunotherapy choice and maintenance for generalized myasthenia gravis in ChinaChao Zhang, Fu‐Dong Shi, Meini Zhang et al.|CNS Neuroscience & Therapeutics|2020Cited by 38
Efficacy and Safety of Teriflunomide in Chinese Patients with Relapsing Forms of Multiple SclerosisWei Qiu, Xianhao Xu, Dehui Huang et al.|Chinese Medical Journal|2018Cited by 15
Status of Immunotherapy Acceptance in Chinese Patients With Multiple Sclerosis: Analysis of Multiple Sclerosis Patient Survival Report 2018Ran Zhou, Weihong Zheng, Qiuming Zeng et al.|Frontiers in Neurology|2021Cited by 13